Plasma levels of vascular endothelial growth factor (VEGF) are predictive of disease-progression in B-cell chronic lymphocytic leukemia (B-CLL).

被引：0
|
作者：
Maurillo, L [1 ]
Del Poeta, G [1 ]
Venditti, A [1 ]
Giovanna, S [1 ]
Buccisano, F [1 ]
Del Principe, MI [1 ]
Tamburini, A [1 ]
Scornajenghi, A [1 ]
Epiceno, AM [1 ]
Piccioni, D [1 ]
Amadori, S [1 ]
机构：
[1] Univ Roma Tor Vergata, I-00173 Rome, Italy
来源：
BLOOD | 2001年 / 98卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1517
引用
收藏
页码：360A / 360A
页数：1
相关论文
共 50 条
  • [41] Expression of bone morphogenetic proteins (BMPs) receptors in patients with B-cell chronic lymphocytic leukemia (B-CLL)
    Dzietczenia, J.
    Wrobel, T.
    Jazwiec, B.
    Mazur, G.
    Butrym, A.
    Poreba, R.
    Kuliczkowski, K.
    INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2010, 32 (06) : E217 - E221
  • [42] In vitro and in vivo cytotoxicity of fludarabine in patients with advanced stage B-cell chronic lymphocytic leukemia (B-CLL)
    Hilgenfeld, E
    Knauf, WU
    Thiel, E
    DRUG RESISTANCE IN LEUKEMIA AND LYMPHOMA II, 1997, 3 : 245 - 253
  • [43] CD31 expression and gene polymorphisms in patients with B-cell chronic lymphocytic leukemia (B-CLL).
    Mainou-Fowler, Tryfonia
    Norden, Jean
    Porteous, Alistair
    Davies, Sian
    Middleton, Peter
    Nicolle, Annette
    Proctor, Stephen
    Dickinson, Anne
    Summerfield, Geoffrey
    BLOOD, 2006, 108 (11) : 322B - 323B
  • [44] Prognosis of B-cell chronic lymphocytic leukemia (CLL): A predictive model for early disease patients.
    Molica, S
    Mauro, FR
    Callea, V
    Gentile, M
    Giannarelli, D
    Lopez, M
    Liso, V
    Mandelli, F
    Foa, R
    BLOOD, 2002, 100 (11) : 596A - 596A
  • [45] Clinico-prognostic implications of increased levels of serum vascular endothelial growth factor in B-cell chronic lymphocytic leukemia.
    Molica, S
    Vitelli, G
    Levato, D
    Gandolfo, GM
    Liso, V
    BLOOD, 1998, 92 (10) : 100A - 100A
  • [46] Interleukin-10 (IL-10) mRNA expression in B-cell chronic lymphocytic leukemia (B-CLL) inversely correlates with progression of disease.
    Sjoberg, J
    AguilarSantelises, M
    Sjogren, AM
    Pisa, EK
    Ljungdahl, A
    Bjorkholm, M
    Jondal, M
    Mellstedt, H
    Pisa, P
    BLOOD, 1995, 86 (10) : 3358 - 3358
  • [47] Karyotype evolution and Rai stage in B-cell chronic lymphocytic lymphoma (B-CLL).
    Wyatt, W
    Meyer, R
    Flynn, H
    Bone, N
    James, CD
    Jelinek, D
    Hanson, C
    Kay, N
    Witzig, T
    Dewald, G
    BLOOD, 2000, 96 (11) : 367A - 367A
  • [48] ELEVATED LEVELS OF SERUM CHEMOTACTIC FACTOR INACTIVATOR (CFI) IN PATIENTS WITH MULTIPLE-MYELOMA (MM) AND B-CELL CHRONIC LYMPHOCYTIC-LEUKEMIA (B-CLL)
    LIEBMAN, HA
    LEVINE, AM
    TONG, M
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1981, 22 (MAR): : 319 - 319
  • [49] Cellular and circulating levels of vascular endothelial growth factor (VEGF) and their correlation with biological parameters identifying high-risk patients in B-cell chronic lymphocytic leukemia
    Molica, S.
    Vitelli, G.
    Cutrona, G.
    Todoerti, K.
    Mirabelli, R.
    Morabito, F.
    Neri, A.
    Ferrarini, M.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 108 - 109
  • [50] Hepatitis B virus (HBV) reactivation in HBsAg negative patients affected by B-cell chronic lymphocytic leukemia (B-CLL).
    Bernuzzi, P
    Lazzaro, A
    Arcari, A
    Anselmi, E
    Berte, R
    Civardi, G
    Moroni, CF
    Vallisa, D
    Cavanna, L
    BLOOD, 2003, 102 (11) : 351B - 351B
12345